Related Experiment Video
Updated: May 20, 2026

A Murine Model of Carotid Aneurysm Formation
Published on: September 9, 2025
MicroRNAs and aneurysm formation
Reinier A Boon1, Stefanie Dimmeler
1Institute of Cardiovascular Regeneration, Center for Molecular Medicine, Goethe University, 60596 Frankfurt, Germany.
Abstract:
Aneurysms occur in large arteries and are characterized by pathological widening of the vessel and thinning of the vessel wall. In the past decade, microRNAs (miRs) have emerged as key regulators of biological processes, and they were recently shown to be involved in aneurysm formation. A few miRs have been proposed to play a role in aneurysm development, such as miR-21, miR-26, and miR-143/145. Several recent studies describe the involvement of miR-29 in aneurysm formation by post-transcriptionally repressing the expression of extracellular matrix proteins. Therapeutic inhibition of miR-29 using anti-miRs attenuates experimental aneurysm formation in mice. This review provides an overview of the upstream regulation of miR-29 as well as the downstream targets of miR-29. It also discusses the potential clinical use for miR-29 inhibitors and the role of other miRs involved in aneurysm formation.
Insights
MicroRNAs (miRs) are involved in aneurysm formation. Inhibiting miR-29 in mice reduced aneurysm development, suggesting potential therapeutic applications for miR-29 inhibitors in treating arterial aneurysms.
Area of Science:
- Vascular Biology
- Molecular Medicine
- Genetics
Background:
- Aneurysms involve pathological widening and thinning of arterial walls.
- MicroRNAs (miRs) are key gene regulators implicated in aneurysm development.
- Specific miRs like miR-21, miR-26, and miR-143/145 have been linked to aneurysms.
Purpose of the Study:
- To review the role of miR-29 in aneurysm formation.
- To explore upstream regulation and downstream targets of miR-29.
- To discuss the clinical potential of miR-29 inhibitors and other relevant miRs.
Main Methods:
- Review of recent studies on microRNA involvement in aneurysm pathogenesis.
- Analysis of miR-29's post-transcriptional repression of extracellular matrix proteins.
- Examination of experimental data on anti-miR-29 therapy in mouse models.
Main Results:
- miR-29 plays a role in aneurysm formation by regulating extracellular matrix proteins.
- Therapeutic inhibition of miR-29 using anti-miRs demonstrated efficacy in reducing experimental aneurysms in mice.
- Several other miRs are also implicated in the development of arterial aneurysms.
Conclusions:
- miR-29 is a significant factor in aneurysm pathogenesis.
- Inhibitors targeting miR-29 show promise as a potential therapy for aneurysms.
- Further research into miR-29 regulation and other miRs is warranted for clinical translation.
Related Concept Videos
MicroRNAs
MicroRNAs
MicroRNAs
Aneurysm I: Introduction
Aneurysm III: Interprofessional Care
